UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

 

SECURITIES EXCHANGE ACT OF 1934

 

For the month of January, 2023

 

001-41208

 

(Commission File Number)

 

NOVONIX LIMITED

 

(Translation of registrant’s name into English)

 

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

 

Form 20-F ☒ Form 40-F ☒

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

---

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit No. Description

 

Exhibit 99.1 Quarterly Activities Report – October-December 2022

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NOVONIX LIMITED

 

By: /s/ Dr John Christopher Burns

Dr. John Christopher Burns

Chief Executive Officer

 

 

 

Date: January 31, 2023

 

---

EXHIBIT 99.1

 

 

 

---

 

 

---

 

 

 

---

 

 

 

 

 

---

 

 

 

---

 

 

 

 

---

 

 

 

 

---

 

 

 

---

 

 

 

 

---

 

 

 

---

 

 

 

 

---

 

 

---